A detailed history of Regent Peak Wealth Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Regent Peak Wealth Advisors LLC holds 16,117 shares of NVO stock, worth $1.92 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
16,117
Holding current value
$1.92 Million
% of portfolio
0.56%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $1.98 Million - $2.37 Million
16,117 New
16,117 $2.3 Million
Q4 2022

Feb 08, 2023

BUY
$102.55 - $135.33 $235,865 - $311,259
2,300 Added 18.56%
14,689 $1.99 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $82,988 - $101,846
871 Added 7.56%
12,389 $1.23 Million
Q2 2022

Aug 11, 2022

BUY
$103.24 - $121.81 $1.19 Million - $1.4 Million
11,518 New
11,518 $1.28 Million
Q1 2021

Apr 28, 2021

SELL
$67.06 - $75.82 $14,552 - $16,452
-217 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$63.89 - $73.8 $13,864 - $16,014
217 New
217 $15,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $269B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Regent Peak Wealth Advisors LLC Portfolio

Follow Regent Peak Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regent Peak Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regent Peak Wealth Advisors LLC with notifications on news.